They are not intended to represent clinical evidence in humans, and IGF-1 LR3 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Shapsis offers virtual consultations for patients across Jacksonville, FL , allowing you to receive professional weight loss guidance from the comfort of your home
Drach J, McQueen T, Engel H, Andreeff M , Robertson KA, Collins SJ, Malavasi F, Mehta K
Supplementation has been shown to increase maximal work output (Siliprandi et al 1990) and VO2 max during sprint exercise (Marcone, et al 1985, Angeline, et al 1986)
Dual-action therapy targeting both GIP and GLP-1 receptors for superior appetite suppression and enhanced metabolic results